Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2006-5-15
pubmed:abstractText
Hepatosplenic gamma-delta T-cell lymphoma is a rare, usually fatal lymphoma and available literature on management is sparse. Allografting is probably the only curative option. We describe a further case with a dramatic, though transient response to Fludarabine and Alemtuzumab combination, following a failure of conventional chemotherapy. Given the dreadful prognosis with conventional chemotherapy, it is a regimen worth pursuing as a disease reduction strategy prior to allograft where appropriate.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, Humanized, http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Neoplasm, http://linkedlifedata.com/resource/pubmed/chemical/Antimetabolites, Antineoplastic, http://linkedlifedata.com/resource/pubmed/chemical/Cisplatin, http://linkedlifedata.com/resource/pubmed/chemical/Cytarabine, http://linkedlifedata.com/resource/pubmed/chemical/Epirubicin, http://linkedlifedata.com/resource/pubmed/chemical/Etoposide, http://linkedlifedata.com/resource/pubmed/chemical/Ifosfamide, http://linkedlifedata.com/resource/pubmed/chemical/Immunosuppressive Agents, http://linkedlifedata.com/resource/pubmed/chemical/Methylprednisolone, http://linkedlifedata.com/resource/pubmed/chemical/Pentostatin, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Antigen, T-Cell..., http://linkedlifedata.com/resource/pubmed/chemical/Vidarabine, http://linkedlifedata.com/resource/pubmed/chemical/alemtuzumab, http://linkedlifedata.com/resource/pubmed/chemical/fludarabine
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0902-4441
pubmed:author
pubmed:issnType
Print
pubmed:volume
76
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
531-4
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:16548918-Adolescent, pubmed-meshheading:16548918-Antibodies, Monoclonal, pubmed-meshheading:16548918-Antibodies, Monoclonal, Humanized, pubmed-meshheading:16548918-Antibodies, Neoplasm, pubmed-meshheading:16548918-Antimetabolites, Antineoplastic, pubmed-meshheading:16548918-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:16548918-Cisplatin, pubmed-meshheading:16548918-Combined Modality Therapy, pubmed-meshheading:16548918-Crohn Disease, pubmed-meshheading:16548918-Cytarabine, pubmed-meshheading:16548918-Epirubicin, pubmed-meshheading:16548918-Epstein-Barr Virus Infections, pubmed-meshheading:16548918-Etoposide, pubmed-meshheading:16548918-Fatal Outcome, pubmed-meshheading:16548918-Gene Rearrangement, delta-Chain T-Cell Antigen Receptor, pubmed-meshheading:16548918-Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor, pubmed-meshheading:16548918-Hematopoietic Stem Cell Transplantation, pubmed-meshheading:16548918-Humans, pubmed-meshheading:16548918-Ifosfamide, pubmed-meshheading:16548918-Immunosuppressive Agents, pubmed-meshheading:16548918-Liver, pubmed-meshheading:16548918-Lymphoma, T-Cell, Peripheral, pubmed-meshheading:16548918-Lymphoproliferative Disorders, pubmed-meshheading:16548918-Male, pubmed-meshheading:16548918-Methylprednisolone, pubmed-meshheading:16548918-Pentostatin, pubmed-meshheading:16548918-Receptors, Antigen, T-Cell, gamma-delta, pubmed-meshheading:16548918-Remission Induction, pubmed-meshheading:16548918-Spleen, pubmed-meshheading:16548918-Transplantation, Homologous, pubmed-meshheading:16548918-Vidarabine
pubmed:year
2006
pubmed:articleTitle
A case of hepatosplenic gamma-delta T-cell lymphoma with a transient response to fludarabine and alemtuzumab.
pubmed:affiliation
Department of Clinical Haematology, Aberdeen Royal Infirmary, Aberdeen, UK. sajjanmittal@yahoo.com
pubmed:publicationType
Journal Article, Case Reports